1 - 25 of 3
Number of results to display per page
TitleDateType
1 Orally Administered SIRTl Activator SRT501 is Neuroprotective for Retinal Ganglion Cells and Suppresses Neurological Dysfunction in a Mouse Model of Multiple Sclerosis2008-03-10Text
2 Retinal Ganglion Cell Loss in a Mouse Model of Optic Neuritis2005-02-15Text
3 Sirtuin-Activating Compounds Prevent Retinal Ganglion Cell Loss During Acute Optic Neuritis2006-02-27Text
1 - 25 of 3